What question did this study set out to answer?

To examine the use of continuous glucose monitoring (CGM) among older adults with diabetes across various healthcare settings and synthesize clinical outcomes.

May 24, 2026Open Access

Continuous glucose monitoring in older adults with diabetes across care settings: A systematic review

Key Points

To examine the use of continuous glucose monitoring (CGM) among older adults with diabetes across various healthcare settings and synthesize clinical outcomes.
Included quantitative studies of adults aged ≥65 years using CGM reporting clinical or user-related outcomes.
Searched databases include MEDLINE, CINAHL, Embase, Scopus, Web of Science, and Cochrane Library up to January 2025.
Quality assessment was performed with NIH tools and narrative synthesis was conducted due to outcome heterogeneity.
Thirty-two studies were included, comprising 10 randomized trials, 17 cohort studies, and 5 cross-sectional studies.
CGM was associated with improved glycemic outcomes, such as reduced HbA1c, increased time in range, and decreased glycemic variability.
Observational studies noted a 34-62.9% reduction in hyperglycemia-related hospitalizations and high persistence rates in CGM use.

Abstract

BACKGROUND: Continuous glucose monitoring (CGM) use is increasing among older adults with diabetes, yet evidence across different care settings remains fragmented. OBJECTIVES: To describe how CGM has been used among older adults with diabetes in community, hospital, and nursinghome settings and to synthesize reported clinical, glycemic, and user-reported outcomes. METHODS: Quantitative studies involving adults aged ≥65 years using CGM and reporting clinical or user-related outcomes were included, while non-English articles, pediatric studies, reviews, and studies without CGM-related outcomes were excluded. MEDLINE, CINAHL, Embase, Scopus, Web of Science, and the Cochrane Library were searched from inception to January 2025. Study quality was assessed using NIH tools for randomized and observational studies. Due to heterogeneity across study designs and outcomes, a narrative synthesis was conducted. RESULTS: Thirty-two studies met the inclusion criteria, including 10 randomized trials, 17 cohort studies, and 5 cross-sectional studies. CGM improved glycemic outcomes by reducing HbA1c, increasing time in range, lowering glycemic variability, and identifying previously unrecognized hypoglycemia. Observational studies reported 34-62.9% reductions in hyperglycemia-related hospitalizations and high persistence of CGM use. Feasibility and acceptability were generally positive, although frail and cognitively impaired adults, as well as institutional settings, were underrepresented. DISCUSSION: Heterogeneity in designs and outcomes precluded meta-analysis; most studies were short-term, conducted in community settings, and lacked standardized measures. CGM improves key glycemic indicators and supports safer diabetes care for many older adults. However, wider evidence across hospitals and nursing homes and among frailer populations is needed. Others: No external funding was received. The review was registered in PROSPERO: CRD420250656434.

Continuous glucose monitoring in older adults with diabetes across care settings: A systematic review

Key Points

Abstract

Cite This Study

Also Consider

Also Consider